Kazia Therapeutics Limited (KZIA)
NASDAQ: KZIA · Real-Time Price · USD
12.13
-0.43 (-3.42%)
May 19, 2026, 2:38 PM EDT - Market open
Kazia Therapeutics Stock Forecast
Stock Price Forecast
According to 3 analysts polled by S&P Global, Kazia Therapeutics stock has a consensus rating of "Buy" and an average price target of $21.34. The average 1-year stock price forecast is 75.93% higher than the current stock price, while the lowest is $18.46 (+52.18%) and the highest is $25.04 (+106.43%).
Price Target: $21.34 (+75.93%)
Analyst Consensus: Buy
* Price targets were last updated on Apr 15, 2026.
Analyst Ratings
The average analyst rating for Kazia Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 4 | 4 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Laidlaw & Co. | Laidlaw & Co. | Strong Buy Initiates $25 | Strong Buy | Initiates | $25 | +106.10% | Apr 15, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $18 | Strong Buy | Reiterates | $18 | +48.39% | Jan 28, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $13 → $18 | Strong Buy | Maintains | $13 → $18 | +48.39% | Dec 12, 2025 |
| Maxim Group | Maxim Group | Strong Buy Maintains $15 → $20 | Strong Buy | Maintains | $15 → $20 | +64.88% | Oct 2, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $2 → $13 | Strong Buy | Maintains | $2 → $13 | +7.17% | Jul 10, 2025 |
Financial Forecast
Revenue This Year
286.11K
from 1.83M
Decreased by -84.36%
Revenue Next Year
179.01K
from 286.11K
Decreased by -37.43%
EPS This Year
-1.14
from -18.89
EPS Next Year
-0.96
from -1.14
Financial currency is AUD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 484,050 | 304,500 | ||||||
| Avg | 286,110 | 179,010 | ||||||
| Low | 98,000 | 59,780 |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -73.5% | 6.4% | ||||||
| Avg | -84.4% | -37.4% | ||||||
| Low | -94.6% | -79.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | -0.01 | - | ||||||
| Avg | -1.14 | -0.96 | ||||||
| Low | -1.96 | -1.68 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | - | - | ||||||
| Avg | - | - | ||||||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.